Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating steroids to protect facial nerve function after vestibular schwannoma surgery; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • steroids

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Vestibular Schwannoma, Facial Nerve Paralysis | Phase 3 | Status: NOT_YET_RECRUITING